Latest Regulatory News

Tian An Australia Limited has reversed last year’s loss to report a $12.08 million profit for H1 2025, while progressing key residential developments across Australia.

Gold Road Resources Limited has agreed to be acquired by Gruyere Holdings Pty Ltd, owned by Gold Fields Limited, in a scheme of arrangement offering $3.29 per share in cash consideration. The Gold Road Board unanimously recommends shareholders vote in favor of the Scheme, subject to no superior proposal emerging.

Orbminco Limited reports promising new geophysical survey results at its Bronze Fox Project in Mongolia while navigating a significant tax dispute currently under appeal.

Kaili Resources has received official approval to begin a targeted drilling program for rare earth elements across three tenements in South Australia’s Limestone Coast region, advancing its exploration ambitions in a promising mineral province.

Microequities Asset Management Group Limited reported a 19.3% rise in net profit for FY25, driven by strong fund performance and a surge in performance fees, while declaring a fully franked final dividend of 2.0 cents per share.

WAM Leaders Limited reported a strong $63.8 million net profit for FY2025 and declared a fully franked final dividend of 4.7 cents per share, despite its investment portfolio underperforming the benchmark index.

Metal Bank Limited has announced its withdrawal from exploration activities in Jordan, citing geopolitical instability and financial guarantees demanded by local authorities as key reasons.

The Takeovers Panel has accepted an undertaking from betr Entertainment, addressing key disclosure and structural concerns in its takeover bid for PointsBet, while declining to declare unacceptable circumstances.

WAM Global Limited reported a robust 39.8% increase in net profit for FY2025, driven by a 19.4% growth in its investment portfolio and declared a fully franked full year dividend of 17 cents per share. The company’s diversified global holdings and disciplined investment approach underpin its strong shareholder returns.

Neurizon Therapeutics faces a delay in FDA review for its lead ALS therapy NUZ-001, with a new decision expected by early October amid agency-wide staffing challenges.

Magnetite Mines Limited has announced a pro rata renounceable rights issue to raise up to $2.65 million, aiming to advance its flagship Razorback iron ore project in South Australia. The offer includes free attaching options and is partially underwritten, reflecting the company’s strategic push towards securing funding and completing key project milestones.

EPX Limited has raised $2 million through a discounted share placement to existing institutional investors, aiming to fuel sales expansion, explore M&A opportunities, and enhance its technology platform.